期刊文献+
共找到58篇文章
< 1 2 3 >
每页显示 20 50 100
Design,delivery and efficacy testing of therapeutic nucleic acids used to inhibit hepatitis C virus gene expression in vitro and in vivo 被引量:9
1
作者 Wolfgang H.Caselmann Matthias Serwe +3 位作者 Thomas Lehmann János Ludwig Brian S.Sproat Joachim W.Engels 《World Journal of Gastroenterology》 SCIE CAS CSCD 2000年第5期626-629,共4页
Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be ... Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be treated effectively.Toimprove this response rate we used antisensetechnologies to inhibit HCV translation as possibleadditional option for experimental treatment.Antisense oligodeoxynucleotides(ODN) are 展开更多
关键词 hepatitis C-like viruses/therapy gene expression in VITRO in vivo nucleic acids/therapeutic use CYTOMEGALOVIRUS
下载PDF
Therapeutic and Medicinal Uses of <i>Aloe vera</i>: A Review 被引量:5
2
作者 Pankaj K. Sahu Deen Dayal Giri +5 位作者 Ritu Singh Priyanka Pandey Sharmistha Gupta Atul Kumar Shrivastava Ajay Kumar Kapil Dev Pandey 《Pharmacology & Pharmacy》 2013年第8期599-610,共12页
The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, ... The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, minerals, enzymes, amino acids, natural sugars and other bioactive compounds with emollient, purgative, anti-microbial, anti inflammatory, antioxidant, aphrodisiac, anti-helmenthic, antifungal, antiseptic and cosmetic values for health care. This plant has potential to cure sunburns, burns and minor cuts, and even skin cancer. The external use in cosmetic primarily acts as skin healer and prevents injury of epithelial tissues, cures acne and gives a youthful glow to skin, also acts as extremely powerful laxative. 展开更多
关键词 ALOE vera Antimicrobial therapeutic MEDICINAL useS Cosmetic Application
下载PDF
Blastocystis hominis as a cause of chronic diarrhea in low-resource settings:A systematic review
3
作者 Stephen Amoak Jonathan Soldera 《World Journal of Meta-Analysis》 2024年第3期30-41,共12页
BACKGROUND Blastocystis hominis(B.hominis),an anaerobic unicellular protist parasite,is known for its diverse clinical manifestations upon infecting the human gastrointestinal tract.Although globally distributed,it is... BACKGROUND Blastocystis hominis(B.hominis),an anaerobic unicellular protist parasite,is known for its diverse clinical manifestations upon infecting the human gastrointestinal tract.Although globally distributed,it is particularly prevalent in developing nations.Examining the symptoms and treatment outcomes of B.hominis infection in low-resource settings holds immense significance,providing healthcare practi-tioners with valuable insights to enhance patient care.AIM To synthesize existing evidence on the symptomatology and treatment outcomes of B.hominis infection in low-resource settings.METHODS Following the Preferred Reporting Items for Systematic Review and Meta-Analysis guidelines,a systematic review was conducted.The search spanned electronic databases including PubMed,Scopus,and Google Scholar.After a comprehensive screening process,a thorough examination of the papers,adhering to inclusion and exclusion criteria,and data extraction from eligible studies was conducted.The findings underwent summarization through simple descriptive analysis.RESULTS The search yielded 1200 papers,with 17 meeting inclusion criteria.Chronic diarrhea due to B.hominis infection was reported in only two studies,while abdominal pain,diarrhea,flatulence,constipation,and nausea/vomiting emerged as the most commonly documented symptoms.Recovery rates after one week of treatment ranged from 71.8%to 100%,and after two weeks,from 60%to 100%.CONCLUSION In low-resource settings,chronic diarrhea resulting from B.hominis infection is infrequent.Common symptoms include abdominal pain,diarrhea,flatulence,constipation,and nausea/vomiting.Post-treatment,clinical outcomes are notably favorable,supporting the recommendation for treatment.Metronidazole is advocated as the first-line agent,with consideration for switching to a second-line option in cases of treatment failure or poor response. 展开更多
关键词 Blastocystis infections Gastrointestinal diseases Treatment outcome Developing countries Metronidazole/therapeutic use
下载PDF
Continuous Wear of Hydrogel Contact Lenses for Therapeutic Use
4
作者 Daisuke Kudo Hiroshi Toshida +1 位作者 Toshihiko Ohta Akira Murakami 《Open Journal of Ophthalmology》 2012年第4期110-113,共4页
Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one w... Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one week of continuous therapeutic wear during 10 years. The reason for prescription of CLs, the primary disease, the duration of CL wear and the complications were assessed retrospectively. Results: The predominant reason for prescription of CLs was relief of pain or a foreign-body sensation (62.3%) and protection of the corneal epithelium (20.6%). The primary disease was post-penetrating keratoplasty (36.8%), followed by corneal epithelial erosion (14.5%), post-lamellar keratoplasty (14.0%) and bullous keratopathy (12.2%). The average duration of wearing single lens was 6.5 ± 3.2 days. The average duration of wearing CLs in total was 9.2 ± 10.7 months. The most frequent problem associated with continuous wear of CLs was their dropping out of CLs (12.3%). The complications associated with CLs included conjunctivitis with papillary hyperplasia, corneal erosion and superficial punctate keratitis, but corneal ulcer and corneal infiltrates were not found. Conclusion: Serious complications were not shown changing the lenses every week to keep to the prescribed time limit for continuous therapeutic wear, even if corneal epithelial barrier function is impaired. 展开更多
关键词 therapeutic use BANDAGE Soft Contact LENS CONTINUOUS WEAR COMPLICATION
下载PDF
Retrieval-balloon-assisted enterography for ERCP after Billroth Ⅱ gastroenterostomy and Braun anastomosis 被引量:8
5
作者 Wen-Guang Wu Wen-Jie Zhang +5 位作者 Jun Gu Ming-Ning Zhao Ming Zhuang Yi-Jing Tao Ying-Bin Liu Xue-Feng Wang 《World Journal of Gastroenterology》 SCIE CAS 2014年第31期10921-10926,共6页
AIM: To describe an optimal route to the Braun anastomosis including the use of retrieval-balloon-assisted enterography.METHODS: Patients who received a Billroth Ⅱ gastroenterostomy(n = 109) and a Billroth Ⅱ gastroe... AIM: To describe an optimal route to the Braun anastomosis including the use of retrieval-balloon-assisted enterography.METHODS: Patients who received a Billroth Ⅱ gastroenterostomy(n = 109) and a Billroth Ⅱ gastroenterostomy with Braun anastomosis(n = 20) between January 2009 and May 2013 were analyzed in this study. Endoscopic ret-rograde cholangiopancreatography(ERCP) was performed under fluoroscopic control using a total length of 120 cm oblique-viewing duodenoscope with a 3.7-mm diameter working channel. For this procedure, we used a triplelumen retrieval balloon catheter in which a 0.035-inch guidewire could be inserted into the "open-channel" guidewire lumen while the balloon could be simultaneously injected and inflated through the other 2 lumens.RESULTS: For the patients with Billroth Ⅱ gastroenterostomy and Braun anastomosis, successful access to the papilla was gained in 17 patients(85%) and there was therapeutic success in 16 patients(80%). One patient had afferent loop perforation, but postoperative bleeding did not occur. For Billroth Ⅱ gastroenterostomy, there was failure in accessing the papilla in 15 patients(13.8%). ERCP was unsuccessful because of tumor infiltration(6 patients), a long afferent loop(9 patients), and cannulation failure(4 patients). The papilla was successfully accessed in 94 patients(86.2%), and there was therapeutic success in 90 patients(82.6%). Afferent loop perforation did not occur in any of these patients. One patient had hemorrhage 2 h after ERCP, which was successfully managed with conservative treatment.CONCLUSION: Retrieval-balloon-assisted enterography along an optimal route may improve the ERCP success rate after Billroth Ⅱ gastroenterostomy and Braun anastomosis. 展开更多
关键词 Retrieval-balloon-assisted enterography Billroth gastroenterostomy Braun anastomosis Optimal enterography route Gastrojejunal anastomosis Efferent loop Endoscopic retrograde cholangiopancreatography Duodenoscope Enterography success rate therapeutic success rate
下载PDF
Comparison of long-lasting therapeutic effects between succimer and penicillamine on hepatolenticular degeneration 被引量:3
6
作者 REN Ming Shan, ZHANG Zhi, WU Jun Xia, LI Fei, XUE Ben Chun and YANG Ren Min 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第6期75-77,共3页
AIM To compare the long term effect of succimer (Suc) with that of penicillamine (Pen) in treating hepatolenticular degeneration (HLD). METHODS One hundred and twenty patients with HLD were divided into 2 groups. ... AIM To compare the long term effect of succimer (Suc) with that of penicillamine (Pen) in treating hepatolenticular degeneration (HLD). METHODS One hundred and twenty patients with HLD were divided into 2 groups. Group A ( n =60) received Suc 750mg , po. bid. Group B ( n =60) received Pen 250mg , po. qid. The period of maintenance treatment varied from 6 months to 3 years, averaging 1 5 years. Symptoms and therapeutic effects were evaluated by modified Goldstein scale. RESULTS The total effectiveness of group A in two different periods of treatment were 80% and 85% respectively, higher than those of group B (58% and 59% respectively) ( P <0 05). Suc also had obvious curative effects for the patients who failed in the use of Pen. There were fewer side effect in group A than in group B ( P <0 05). Suc and Pen could increase urinary copper excretion effectively and continually. CONCLUSION Suc is more effective and safer than Pen. Clinically, it can replace Pen as first choice drug for long term maintenance therapy of HLD. 展开更多
关键词 hepatolenticular degeneration/drug THERAPY succimer/therapeutic use penicillamine/therapeutic use
下载PDF
Functional dyspepsia of ulcer-dysmotility type:clinical incidence and therapeutic strategy 被引量:3
7
作者 WANG XiaoZhong and LIN GuZhen 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第4期95-96,共2页
Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhe... Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhenSubjectheaadings... 展开更多
关键词 dyspepsia/drug therapy famotidine/therapeutic use cisapride/therapeutic use peptic ULCER gastrointestinal motility
下载PDF
Therapeutic role of template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract 被引量:5
8
作者 Tsunenori Kondo Toshio Takagi Kazunari Tanabe 《World Journal of Clinical Oncology》 CAS 2015年第6期237-251,共15页
Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional n... Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional nodes for tumors of the right renal pelvis or the right upper two-thirds of the ureter. A prospective study showed that an anatomical templatebased lymphadenectomy significantly improved patient survival in tumors of the renal pelvis. This benefit was more evident for patients with p T2 stage tumors or higher. The risk of regional node recurrence is significant reduced by template-based lymphadenectomy,which is likely to be associated with improved patient survival. The removal of lymph node micrometastases is assumed to be the reason for therapeutic benefit following lymphadenectomy. The number of resected lymph nodes can be used to assess the quality of lymphadenectomy,but not to determine the extent of lymphadenectomy. The guidelines currently recommend lymphadenectomy for patients with muscle-invasive disease,even though the current recommendation grades are still low. The present limitation of lymphadenectomy is the lack of standardization of the extent of lymphadenectomy and the randomized trials. Further studies are warranted to collect the evidence to support lymphadenectomy. 展开更多
关键词 LYMPHADENECTOMY LYMPH node EXCISION UROTHELIAL carcinoma Treatment outcome therapeutic uses Diagnosis GUIDELINE
下载PDF
Controversies regarding transplantation of mesenchymal stem cells
9
作者 Tsvetelina Velikova Tereza Dekova Dimitrina Georgieva Miteva 《World Journal of Transplantation》 2024年第2期48-61,共14页
Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intric... Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intricate landscape of MSC controversies,drawing upon 15 years of clinical experience and research.We delve into the fundamental properties of MSCs,exploring their unique immuno-modulatory capabilities and surface markers.The heart of our inquiry lies in the controversial applications of MSC transplantation,including the perennial debate between autologous and allogeneic sources,concerns about efficacy,and lingering safety apprehensions.Moreover,we unravel the enigmatic mechanisms surro-unding MSC transplantation,such as homing,integration,and the delicate balance between differentiation and paracrine effects.We also assess the current status of clinical trials and the ever-evolving regulatory landscape.As we peer into the future,we examine emerging trends,envisioning personalized medicine and innovative delivery methods.Our review provides a balanced and informed perspective on the controversies,offering readers a clear understanding of the complexities,challenges,and potential solutions in MSC transplantation. 展开更多
关键词 Mesenchymal stem cells Transplantation controversies Regenerative medicine Autoimmune diseases Chronic inflammatory illnesses Tumor growth METASTASIS therapeutic potential Clinical use of mesenchymal stem cell
下载PDF
Clinacanthus nutans:a review of the medicinal uses,pharmacology and phytochemistry 被引量:10
10
作者 Md.Ariful Alam Sahena Ferdosh +4 位作者 Kashif Ghafoor Md.Abdul Hakim Abdul Shukor Juraimi Alfi Khatib Md.Zaidul I.Sarker 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2016年第4期393-399,共7页
Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bite... Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bites,lesions caused by herpes simplex virus,diabetes,and gout in Malaysia.Indonesia.Thailand and China.Phylochemieal investigations documented the varied contents of bioaclive compounds from litis plant namely flavonoids,glycosides,glycoglyeerolipids.cerebrosides and monoacylmonogalatosylglycerol.The pharmacological experiment proved that various types of extracts and pure compounds from this species exhibited a broad range of biological properties such as anti-inflammatory,antiviral,antioxidant,and anti-diabetic activities.The lindings of toxicity study showed that extracts from this plant did not show any toxicity thus it can be used as strong therapeutic agents for specific diseased conditions.However,further experiments on chemical components and their mode of action showing biological activities are required to elucidate the complete phytochemical profile and assess to confirm their suitability tor future drugs.This review summarizes the medicinal uses,phytochemistry and pharmacology of this plant in order to explore its therapeutic potential and gaps necessitating for prospected research work. 展开更多
关键词 Clinacanthus nutans MEDICINAL useS PHYTOCHEMICALS PHARMACOLOGY therapeutic potential
下载PDF
High-intensity focused ultrasound extracorporeal ablation of liver tissuesin rabbits
11
《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第2期16-16,共1页
HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZ... HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZhaoYou1,YUYao1,B... 展开更多
关键词 LIVER neoplasms experimental/therapy ultrasonic THERAPY iodized oil/therapeutic use liver/radiation effects randomized controlled trials
下载PDF
胃空肠裤形吻合与毕Ⅰ式吻合术在腹腔镜远端胃癌根治术中的应用效果对比 被引量:2
12
作者 郭涛 焦光辉 林功攀 《河南医学研究》 CAS 2023年第15期2805-2808,共4页
目的比较胃空肠裤形吻合与毕Ⅰ式吻合术在腹腔镜远端胃癌根治术中的应用效果及安全性。方法选取2019年1月至2022年1月在平煤神马医疗集团总医院接受腹腔镜远端胃癌根治术的90例患者,根据消化道重建方式为裤形吻合组(43例)和毕Ⅰ式吻合组... 目的比较胃空肠裤形吻合与毕Ⅰ式吻合术在腹腔镜远端胃癌根治术中的应用效果及安全性。方法选取2019年1月至2022年1月在平煤神马医疗集团总医院接受腹腔镜远端胃癌根治术的90例患者,根据消化道重建方式为裤形吻合组(43例)和毕Ⅰ式吻合组(47例)。比较两组围手术期相关指标,术后1、2、3 d的视觉模拟评分法(VAS)评分以及胃镜RGB分级、胃镜洛杉矶分级、生活质量和并发症发生情况。结果裤形吻合组手术时间、术后排气时间、住院时间短于毕Ⅰ式吻合组(P<0.05),裤形吻合组术中出血量、淋巴结清扫数目少于毕Ⅰ式吻合组(P<0.05)。术后1、2 d裤形吻合组VAS评分低于毕Ⅰ式吻合组(P<0.05)。裤形吻合组术后6、12个月,食物残留、胃炎、胆汁反流的胃镜RGB分级≥1级率均低于毕Ⅰ式吻合组(P<0.05)。裤形吻合组术后6、12个月胃镜洛杉矶分级≥A级率分别为23.26%、23.26%,低于毕Ⅰ式吻合组的44.68%、48.94%(P<0.05)。裤形吻合组术后6、12个月生活质量优于毕Ⅰ式吻合组(P<0.05)。结论胃空肠裤形吻合应用于腹腔镜远端胃癌根治术中,可有效缩短手术时间和住院时间,减少术中出血,且可有效改善术后胆汁反流的问题,提高术后生活质量,且安全性高。 展开更多
关键词 胃癌 胃空肠裤形吻合 毕Ⅰ式吻合术 腹腔镜远端胃癌根治术 治疗效果 安全性
下载PDF
The role of drug utilization evaluation in medical sciences
13
作者 Ruby Gangwar Arvind Kumar +2 位作者 Abrar Ahmed Zargar Amit Sharma Ranjeet Kumar 《Global Health Journal》 2023年第1期3-8,共6页
Background:Drug utilization evaluation(DUE)is defined by the World Health Organization(WHO)and focuses on the medical,social,and economic consequences of pharmaceutical marketing,distribution,prescribing,and usage in ... Background:Drug utilization evaluation(DUE)is defined by the World Health Organization(WHO)and focuses on the medical,social,and economic consequences of pharmaceutical marketing,distribution,prescribing,and usage in society.The WHO recommends a physician to every 1000 people.According to the recent data from the Health Ministry in 2019,in which 1.16 million doctors are of active population with just 80%,or 0.9 million,practicing.As a result,a ratio of 0.68 doctors for every 1000 people,which is much below as per the WHO reports.This article describes history,types,WHO guidelines,need and purpose of DUE.Objective:The main aim of this paper is to provide information about the rational use of medication in outpa­tient and inpatient department with special emphasis of DUEs.It also provides awareness directly to healthcare professionals,researchers,academicians,pharmacist and nurses to reduce the irrationality of medicines.Methods:The method used to compile this review information gathered from websites,Google scholar,PubMed,Research gate,and studies published on DUE from July 20 to Oct 22 were included as source of information.Results:We studied more than 35 published study on DUE,that reveals most of the physicians prescribed branded drugs not generic drugs,but WHO prescribing indicator allows to prescribe generic drugs in the hospital pharmacy to maintain better inventory control.It may also help to prevent pharmacist misunderstanding during dispensing.Conclusion:The use of generic prescription names avoids the possibility of medication product duplication and lowers patient costs.It is important to remember that incorrect medication prescriptions have impact on both patients and their family members.WHO indicators identify irrational prescribing behaviours to make therapy more rational and cost-effective. 展开更多
关键词 Anatomical therapeutic chemical classification Drug utilization evaluation Prescribing indicators Pregnancy risk classification Rational use of the drug
下载PDF
USE OF CELL-BASED BIOASSAY FOR THE QUALITY CONTROL OF BOTANICAL THERAPEUTICS
14
作者 Doo Suk Lee Min-Jung Bae Sunyoung Kim 《World Journal of Traditional Chinese Medicine》 2015年第4期91-91,共1页
The single most important factor in modernization efforts of traditional oriental medicines is the limited understanding of active compounds responsible for claimed therapeutic effects.Indeed,the unknown identity of b... The single most important factor in modernization efforts of traditional oriental medicines is the limited understanding of active compounds responsible for claimed therapeutic effects.Indeed,the unknown identity of biologically active molecules generates major difficulties associated with botanical therapeutics in general.This includes management of raw materials,poor understanding of 展开更多
关键词 use OF CELL-BASED BIOASSAY FOR THE QUALITY CONTROL OF BOTANICAL therapeuticS PG
原文传递
冠状动脉旁路移植术中主动脉近端吻合装置的临床应用 被引量:3
15
作者 刘培生 陈鑫 +2 位作者 石开虎 徐明 蒋英硕 《中国胸心血管外科临床杂志》 CAS 2008年第4期255-259,共5页
目的评价主动脉近端吻合装置在冠状动脉旁路移植术(CABG)中应用的初步疗效,进一步论证其安全性及可行性。方法自2006年1月至2007年5月我们共对50例冠心病患者在施行CABG主动脉近端吻合时使用吻合装置[Novare Enclose Ⅱ系统(Novare S... 目的评价主动脉近端吻合装置在冠状动脉旁路移植术(CABG)中应用的初步疗效,进一步论证其安全性及可行性。方法自2006年1月至2007年5月我们共对50例冠心病患者在施行CABG主动脉近端吻合时使用吻合装置[Novare Enclose Ⅱ系统(Novare Surgical System,Cupertino,CA)]吻合。术前合并高血压病28例、糖尿病17例、陈旧性心肌梗死18例、陈旧性脑梗死15例。其中行体外循环CABG(CABG)16例,非体外循环CABG(OPCAB)34例。共使用主动脉近端吻合装置吻合175次(3.2±1.37),其中静脉吻合152次、游离左乳内动脉(LIMA)12次、桡动脉11次。结果术中移植血管经即时血流仪测量血流满意。未出现与近端吻合装置有关的并发症,无院内死亡。术后2例因胸腔引流量偏多而二次开胸止血,2例因呼吸功能不全行气管切开,1例因糖尿病、肾病、肾功能不全而行血液透析,5例患者经过积极治疗,治愈出院。术后未出现脑部相关并发症,未出现严重的心脏事件。术后1-3个月对50例患者通过电话以及信件随访,生存率为100%,心脏相关事件豁免率100%。结论主动脉近端吻合装置初步应用临床安全、有效,但其中、远期效果尚需进一步观察。 展开更多
关键词 冠状动脉旁路移植术 近端吻合装置 疗效
下载PDF
Ⅰ期切除吻合术治疗左半结肠癌合并急性肠梗阻的可行性研究 被引量:8
16
作者 侯建峰 王卫刚 《实用临床医药杂志》 CAS 2019年第12期36-38,共3页
目的分析对左半结肠癌合并急性肠梗阻患者行Ⅰ期切除吻合术治疗的可行性。方法对本院收治的46例左半结肠癌合并急性肠梗阻患者的临床资料进行回顾性分析,将其中采用分期手术治疗的23例患者设为对照组,将其中采用Ⅰ期切除吻合术治疗的23... 目的分析对左半结肠癌合并急性肠梗阻患者行Ⅰ期切除吻合术治疗的可行性。方法对本院收治的46例左半结肠癌合并急性肠梗阻患者的临床资料进行回顾性分析,将其中采用分期手术治疗的23例患者设为对照组,将其中采用Ⅰ期切除吻合术治疗的23例患者设为实验组,观察并记录2组治疗效果。结果实验组手术时间、胃肠功能恢复时间、住院时间均短于对照组(P<0.05);2组淋巴结清除数量、腹腔感染、吻合口漏等并发症发生率比较差异无统计学意义(P>0.05);2组切口感染、总并发症发生率比较,差异有统计学意义(P<0.05)。结论Ⅰ期切除吻合术治疗左半结肠癌合并急性肠梗阻安全可行,能减轻患者痛苦,缩短患者住院时间,提高患者生活质量。 展开更多
关键词 左半结肠癌 急性肠梗阻 Ⅰ期切除吻合术 治疗效果
下载PDF
化瘀生脉方对血管吻合术后内皮细胞愈合影响的实验研究 被引量:2
17
作者 晋大祥 杨达文 +5 位作者 杨志东 王立 赵京涛 姚珍松 张顺聪 梁德 《中医正骨》 2006年第10期7-8,共2页
为研究化瘀生脉方对小血管吻合术后内皮细胞愈合机制的影响。采用SD大鼠尾动脉切断后作端端吻合的模型。按用药不同随机分成化瘀生脉组和空白对照组,每组16只。每组再按血管吻合术后22、4、48小时和7天切取标本时间的不同随机分为4组。... 为研究化瘀生脉方对小血管吻合术后内皮细胞愈合机制的影响。采用SD大鼠尾动脉切断后作端端吻合的模型。按用药不同随机分成化瘀生脉组和空白对照组,每组16只。每组再按血管吻合术后22、4、48小时和7天切取标本时间的不同随机分为4组。样本用扫描电镜观察吻合口处内皮细胞的修复过程。结果显示术后2、24、48小时和7天,化瘀生脉组缝线表面完全覆盖率均高于空白对照组,经成组设计两样本比较的秩和检验,统计学上有显著性差异。术后2、24、48小时,化瘀生脉组在针孔及缝线表面的覆盖成分以纤维素、内皮细胞为主,构成比不同于空白对照组,经χ2检验,其差异有非常显著性意义(P<0.01)。表明化瘀生脉方具有抑制血小板在针孔处聚集的作用,能够促进纤维素对针孔及缝线表面的覆盖,能够促进内皮细胞的生长,从而可以防治术后血栓形成。 展开更多
关键词 血管吻合术/显微外科 内皮细胞愈合/药物作用 化瘀生脉/治疗应用
下载PDF
缝合器、吻合器在消化道手术中的应用体会 被引量:1
18
作者 肖永来 齐宏 张琳 《菏泽医学专科学校学报》 2001年第3期36-37,共2页
目的 探讨缝合器、吻合器在消化道手术中的应用。方法 应用XF - 60 / 90 ,GF - 1吻合器进行各类消化道手术。结果 运用缝合器、吻合器进行 186例手术 ,仅 3例出现并发症。结论 消化道手术中应用缝合器、吻合器有利于防止各种术后并... 目的 探讨缝合器、吻合器在消化道手术中的应用。方法 应用XF - 60 / 90 ,GF - 1吻合器进行各类消化道手术。结果 运用缝合器、吻合器进行 186例手术 ,仅 3例出现并发症。结论 消化道手术中应用缝合器、吻合器有利于防止各种术后并发症 ,且有操作简便 。 展开更多
关键词 缝合器/治疗应用 吻合器/治疗应用 消化道疾病/外科手术
下载PDF
经主动脉弓前行食管床内胸膜顶食管胃器械吻合术
19
作者 徐立 赵辉 +1 位作者 任宪伟 华新民 《中国实用医药》 2008年第17期38-39,共2页
目的探讨食管癌切除后食管胃主动脉后吻合的简便方法。方法食管癌切除后,将管状胃经主动弓后绕过其上缘、牵到主动脉弓前与食管在胸膜顶以管状吻合器吻合,吻合后将食管胃还纳食管床内。结果采取此食管胃吻合法共48例,随访2个月~3年,平... 目的探讨食管癌切除后食管胃主动脉后吻合的简便方法。方法食管癌切除后,将管状胃经主动弓后绕过其上缘、牵到主动脉弓前与食管在胸膜顶以管状吻合器吻合,吻合后将食管胃还纳食管床内。结果采取此食管胃吻合法共48例,随访2个月~3年,平均约10个月,无吻合口瘘,心血管并发少,操作简便,省时约20~30 min。结论经主动脉弓前行食管床内胸膜顶食管器械吻合操作简便、省时。 展开更多
关键词 食管癌 外科治疗 吻合术
下载PDF
Combination of "low-dose" ribavirin and interferon alfa-2a therapy followed by interferon alfa-2a monotherapy in chronic HCV-infected nonresponders and relapsers after interferon alfa-2a monotherapy 被引量:19
20
作者 Perdita Wietzke-Braun Volker Meier +1 位作者 Felix Braun Giuliano Ramadori 《World Journal of Gastroenterology》 SCIE CAS CSCD 2001年第2期222-227,共6页
AIM To report on the efficacy, safety and tolerability of interferon alfa-2a combined with a "low dose" of ribavirin for relapsers and non responders to alpha interferon monotherapy.METHODS Thirty-four chron... AIM To report on the efficacy, safety and tolerability of interferon alfa-2a combined with a "low dose" of ribavirin for relapsers and non responders to alpha interferon monotherapy.METHODS Thirty-four chronic hepatitis C virus-infected non-responders to interferon alfa2a monotherapy (a course of at least 3 months treatment) and 13 relapsers to interferon alfa 2a monotherapy (a dose of 3 to 6 million units three times per week for at least 20 weeks but not more than 18 months) were treated with the same dose of interferon alfa-2a used before (3 to 6 million units three times per week) and ribavirin (10 mg/ kg daily) for 6 months. In complete responders, interferon alfa-2a was administered for further 6 months at the same dose used before as monotherapy.RESULTS Seven (20.6%) of 34 non-responders stopped the combined therapy due to adverse events, including two patients with histological and clinical Child A cirrhosis. In 17/27 (63%)non-responders, the combined therapy was stopped after three months because of non-response. Ten of the 27 non-responders completed the 1;2-month treatment course. At a mean follow up of 28 months (16- 37 months)after the treatment, 4/10 (15%) previous non-responders still remained complete responders,All 13 previous relapsers completed the 12-month treatment course. At a mean follow up of 22months (9 - 36 months) after treatment, 6/13(46%) the previous relapsers were stillsustained complete responders.CONCLUSION Our treatment schedule of the combined therapy for 6 months of interferon alfa2a with a low dose of ribavirin (10 mg/kg/day)followed by 6 months of interferon alfa-2amonotherapy is able to induce a sustainedcomplete response rate in 15% of non-responders and 46% of relapsers with chronic hepatitis C virus-related liver diseases comparable to those obtained with the standarddoses of ribavirin 1000 - 1200 mg/day.Randomized prospective controlled trials using lower total amounts of ribavirin in combination with interferon should be performed. 展开更多
关键词 hepatitis C chronic/drug therapy INTERFERON alpha-2a/therapeutic use INTERFERON alpha-2a/administration & DOSAGE ribavirin/administration & DOSAGE ribavirin/therapeutic use
下载PDF
上一页 1 2 3 下一页 到第
使用帮助 返回顶部